Subject(s)
Darier Disease , Humans , Darier Disease/complications , Darier Disease/diagnosis , EyelidsSubject(s)
Coloboma , Cysts , Microphthalmos , Orbital Diseases , Humans , Young Adult , Orbit , Microphthalmos/complications , Microphthalmos/diagnosis , Coloboma/complications , Coloboma/diagnosis , Orbital Diseases/complications , Orbital Diseases/diagnosis , Cysts/complications , Cysts/diagnosisSubject(s)
Dacryocystitis , Lacrimal Apparatus Diseases , Lacrimal Apparatus , Tuberculosis , Dacryocystitis/diagnosis , Dacryocystitis/etiology , Edema/complications , Granuloma/complications , Humans , Lacrimal Apparatus/diagnostic imaging , Lacrimal Apparatus Diseases/complications , Tuberculosis/complicationsABSTRACT
Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, cough, and shortness of breath and was COVID-PCR positive. During her 10-day hospital stay, she received oxygen, antibiotics, heparin and corticosteroids intravenously and then orally. After her recovery from COVID-19, the patient developed progressive visual loss in both eyes: her corrected visual acuity was 3/10 in both eyes, the anterior segment was normal, and the vitreous was clear. Fundus examination, optical coherence tomography and fluorescein angiography showed bilateral serous retinal detachments. Her course was characterized by improvement in visual acuity and regression of the retinal detachments. Central serous chorioretinopathy can occur after COVID-19 infection due to the administration of corticosteroids; thus, ophthalmologic examination is essential to detect ocular involvement as early as possible.
Subject(s)
COVID-19 , Central Serous Chorioretinopathy , Adult , Central Serous Chorioretinopathy/diagnosis , Central Serous Chorioretinopathy/etiology , Female , Fluorescein Angiography , Fundus Oculi , Humans , SARS-CoV-2 , Tomography, Optical CoherenceSubject(s)
Hemangioma, Cavernous , Strabismus , Child , Hemangioma, Cavernous/complications , Hemangioma, Cavernous/diagnosis , Humans , RetinaABSTRACT
INTRODUCTION: Blepharophimosis ptosis epicanthus inversus syndrome (BPES) is a rare congenital hereditary abnormality. It includes complex orbital-palpebral malformations, causing aesthetic and functional ramifications. Management of BPES requires two steps : diagnosis and treatment. PATIENTS AND METHODS: We performed a retrospective descriptive study of 44 patients (88 eyelids) with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). In our series, we opted for two-stage surgery in 28 cases : epicanthus-telecanthus surgery followed by ptosis surgery. Simultaneous surgery was performed in 5 cases. RESULTS: The mean age at the first visit was 6 years (6.1±6.4). The mean age of our patients at the time of the first surgery was 6.6 years. Epicanthus surgery was performed in 35 cases. The two techniques used to correct epicanthus were Y-V plasty in 30 cases (85.7%, n=35) and Y-V+double Z plasty in 5 cases (14.3%, n=35). Correction of the telecanthus was performed at the same time by a medial canthal tendon plication in 31 cases (88.6%, n=35) or transnasal canthopexy in 4 cases (11.4%, n=35). The mean age at the time of ptosis surgery was 7.23 years (±6.25), ranging from 8 months to 27 years. Ptosis surgery was performed in 41 cases (79 eyelids), of which 3 patients underwent unilateral ptosis surgery due to asymmetrical ptosis. The techniques used were levator resection in 64 eyelids and frontal suspension in 15 eyelids. CONCLUSION: BPES is often clinically diagnosed. The difficulty in management lies in the complex surgery required. There is no established consensus regarding surgical techniques or the timing of the surgeries.
Subject(s)
Blepharophimosis , Blepharoptosis , Blepharophimosis/diagnosis , Blepharophimosis/surgery , Blepharoptosis/diagnosis , Blepharoptosis/epidemiology , Blepharoptosis/etiology , Child , Humans , Referral and Consultation , Retrospective Studies , Tunisia/epidemiologySubject(s)
Cataract/diagnostic imaging , Exfoliation Syndrome/diagnostic imaging , Aged , Blindness/diagnostic imaging , Blindness/etiology , Blindness/surgery , Cataract/pathology , Cataract Extraction , Exfoliation Syndrome/complications , Exfoliation Syndrome/pathology , Exfoliation Syndrome/surgery , Female , HumansSubject(s)
Choroid Diseases/diagnosis , Choroid/diagnostic imaging , Inflammation/diagnosis , Orbital Diseases/diagnosis , Adult , Choroid/pathology , Choroid Diseases/complications , Exophthalmos/diagnosis , Exophthalmos/etiology , Exophthalmos/pathology , Humans , Inflammation/complications , Male , Orbital Diseases/complications , Tomography, Optical Coherence , TunisiaABSTRACT
PURPOSE: To assess the vision-specific quality-of-life (VS-QoL) of glaucoma patients followed at Farhat Hached university hospital, Sousse-Tunisia, and identify clinical and sociodemographic factors potentially affecting it. METHODS: This was a cross-sectional study enrolling one-hundred twenty patients followed for primary open angle glaucoma (POAG). All the patients successfully responded to the Arabic version of the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ 25). Quality of life was quantified in terms of scores (0-100) and correlated with sociodemographic and clinical factors. RESULTS: One hundred and twenty patients were studied. The mean age was 62.38±10.68years. The global mean score (GMS) score was 70.11±18.45% ranging from 23.71 to 98%. Urban residence was associated with a better total score (P=0.01). Educational background was correlated with the subscale scores of distant activities (P=0.01), social functioning (P=0.03), physical activity limitations (P=0.01) and peripheral vision (P=0.01). The total NEI-VFQ 25 had a statistically significantly negative correlation with the duration of the glaucoma (P=0.002), the cup to disc ratio of the better and the worse eye (P<10-4), the visual acuity of the better and the worse eye (P<10-4), but not with the intraocular pressure. A higher number of glaucoma medications had a negative impact on the total score (P=0.03) and the subscales of physical activity limitations (P=0.04) and driving (P=0.002). CONCLUSIONS: Vision-specific quality of life of glaucoma patients, as measured by the NEI-VFQ 25, is correlated to many sociodemographic and clinical elements. QoL evaluation is an essential factor to be considered in the management of glaucoma patients. In our context, research should be directed first to the validation of a questionnaire in the local dialect.